Investor Presentaiton

Evolving BMS R&D: World-class organization with increased focus on productivity & scientific leadership Scientific Leadership Cardiovascular Hematology Oncology Immunology Neuroscience Top-tier productivity Increasing Probability of Success Increasing INDs Established leadership Reducing Cycle Times Re-establishing Capitalize on differentiated platforms Targeted Protein Cell Therapy Degradation Biotherapeutics Ill Bristol Myers Squibb™ Small Molecules Retain & attract the best talent in the industry Enabled by a high-performance culture Leveraging partnerships and Al/Digital Technologies Not for Product Promotional Use 9

View entire presentation